Edwards Lifesciences Corp (EW)vsINVO Fertility, Inc. (IVF)
EW
Edwards Lifesciences Corp
$94.44
+2.90%
HEALTHCARE · Cap: $52.90B
IVF
INVO Fertility, Inc.
$0.56
-9.74%
HEALTHCARE · Cap: $2.62M
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 86372% more annual revenue ($6.51B vs $7.53M). EW leads profitability with a 15.4% profit margin vs -92.3%. EW earns a higher WallStSmart Score of 53/100 (C-).
EW
Buy53
out of 100
Grade: C-
IVF
Hold37
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+68.5%
Fair Value
$251.45
Current Price
$94.44
$157.01 discount
Intrinsic value data unavailable for IVF.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Large-cap with strong market position
Strong operational efficiency at 29.8%
Reasonable price relative to book value
Conservative balance sheet, low leverage
16.7% revenue growth
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 25.4%
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Debt/Equity, Altman Z-Score, Market Cap. Profitability is solid with margins at 15.4% and operating margin at 29.8%. Revenue growth of 13.6% demonstrates continued momentum.
Bull Case : IVF
The strongest argument for IVF centers on Price/Book, Debt/Equity, Revenue Growth. Revenue growth of 16.7% demonstrates continued momentum.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 54.6x leaves little room for execution misses.
Bear Case : IVF
The primary concerns for IVF are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
EW profiles as a mature stock while IVF is a growth play — different risk/reward profiles.
IVF carries more volatility with a beta of 1.44 — expect wider price swings.
IVF is growing revenue faster at 16.7% — sustainability is the question.
EW generates stronger free cash flow (585M), providing more financial flexibility.
Bottom Line
EW scores higher overall (53/100 vs 37/100), backed by strong 15.4% margins and 13.6% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →INVO Fertility, Inc.
HEALTHCARE · MEDICAL DEVICES · USA
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. The company is headquartered in Sarasota, Florida.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?